The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia
Open Access
- 1 September 2019
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 25 (9) , e277-e284
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK
- Bloodwise
This publication has 54 references indexed in Scilit:
- A brief, but comprehensive, guide to clonal evolution in aplastic anemiaHematology-American Society Hematology Education Program, 2018
- Guidelines for the diagnosis and management of adult aplastic anaemiaBritish Journal of Haematology, 2015
- Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015Bone Marrow Transplantation, 2015
- Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantationBlood, 2015
- Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic AnemiaNew England Journal of Medicine, 2011
- Antithymocyte Globulin and Cyclosporine for Severe Aplastic AnemiaJAMA, 2003
- Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemiaBlood, 2003
- Malignant Tumors Occurring after Treatment of Aplastic AnemiaNew England Journal of Medicine, 1993
- Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without CyclosporineNew England Journal of Medicine, 1991
- Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortalityBlood, 1976